GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.26) by 38.46 percent. This is a 52.94 percent increase over losses of $(0.34) per share from the same period last year.
Over $10M Bet On Sensata Technologies? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares,…